CAPTURE: Cancer and COVID-19 antiviral immune monitoring study.

被引：0
|
作者：
Fendler, Annika [1 ]
Boos, Laurie [2 ,3 ]
Au, Lewis [1 ]
Shepherd, Scott [1 ,2 ]
Byrne, Fiona [1 ]
Edmonds, Kim [2 ,3 ]
Carlyle, Ellie [2 ,3 ]
Del Rosario, Lyra [2 ,3 ]
Shum, Ben [2 ,3 ]
Larkin, James [2 ,3 ]
Pickering, Lisa [2 ,3 ]
Furness, Andrew [2 ,3 ]
Turajlic, Samra [1 ,2 ]
机构：
[1] Francis Crick Inst, Canc Dynam Lab, London, England
[2] Royal Marsden NHS Fdn Trust, Renal Unit, London, England
[3] Royal Marsden NHS Fdn Trust, Skin Unit, London, England
来源：
CLINICAL CANCER RESEARCH | 2020年 / 26卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-091
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in cancer patients with COVID-19
    Pan, Yun
    Tan, Jiaxiong
    Li, Jinzhong
    Li, Taoyuan
    Li, Jieying
    Cao, Yang
    Yang, Liu
    Lin, Xunge
    Li, Minran
    Liang, Xujing
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [32] Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
    Satyanarayana, Gowri
    Enriquez, Kyle T.
    Sun, Tianyi
    Klein, Elizabeth J.
    Abidi, Maheen
    Advani, Shailesh M.
    Awosika, Joy
    Bakouny, Ziad
    Bashir, Babar
    Berg, Stephanie
    Bernardes, Marilia
    Egan, Pamela C.
    Elkrief, Arielle
    Feldman, Lawrence E.
    Friese, Christopher R.
    Goel, Shipra
    Gomez, Cyndi Gonzalez
    Grant, Keith L.
    Griffiths, Elizabeth A.
    Gulati, Shuchi
    Gupta, Shilpa
    Hwang, Clara
    Jain, Jayanshu
    Jani, Chinmay
    Kaltsas, Anna
    Kasi, Anup
    Khan, Hina
    Knox, Natalie
    Koshkin, Vadim S.
    Kwon, Daniel H.
    Labaki, Chris
    Lyman, Gary H.
    McKay, Rana R.
    McNair, Christopher
    Nagaraj, Gayathri
    Nakasone, Elizabeth S.
    Nguyen, Ryan
    Nonato, Taylor K.
    Olszewski, Adam J.
    Panagiotou, Orestis A.
    Puc, Matthew
    Razavi, Pedram
    Robilotti, Elizabeth, V
    Santos-Dutra, Miriam
    Schmidt, Andrew L.
    Shah, Dimpy P.
    Shah, Sumit A.
    Vieira, Kendra
    Weissmann, Lisa B.
    Wise-Draper, Trisha M.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [33] Comment on: Favipiravir, an antiviral for COVID-19?
    Chachaima-Mar, Jorge
    Perez-Castilla, Jesus
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) : 279 - 280
  • [34] Efficiency of antiviral treatment in COVID-19
    Negrut, Nicoleta
    Codrean, Adriana
    Hodisan, Ioana
    Bungau, Simona
    Tit, Delia Mirela
    Marin, Ruxandra
    Behl, Tapan
    Banica, Florin
    Diaconu, Camelia C.
    Nistor-Cseppento, Delia Carmen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [35] Pfizer tests COVID-19 antiviral
    Halford, Bethany
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (37) : 9 - 9
  • [36] Optional antiviral agents for the COVID-19
    Xiao Tingting
    Yang Kai
    Huang Chen
    Zhu Yunying
    Wu Zhenzhu
    Xiao Yonghong
    Chinese Journal of Clinical Infectious Diseases, 2020, 13 (02) : E012 - E012
  • [37] Antiviral therapy and immunotherapy of COVID-19
    Crespillo, Clara
    Moreno, Santiago
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 57 - 59
  • [38] Pfizer to license COVID-19 antiviral
    McCoy, Michael
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (42) : 19 - 19
  • [39] Antiviral therapy in patients with COVID-19
    Augustin, Max
    Hallek, Michael
    Nitschmann, Sirka
    INNERE MEDIZIN, 2022, 63 (08): : 900 - 902
  • [40] Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS)
    Doroshow, D.
    Schmidt, A. L.
    Bakouny, Z.
    Bhalla, S.
    Steinharter, J. A.
    Tremblay, D.
    Awad, M. M.
    Kessler, A. J.
    Bouchard, G.
    Evans, M.
    Busser, F.
    Zimmerman, B. S.
    Curran, C. R.
    Jun, T.
    Haddad, R.
    Qin, Q.
    Nuzzo, P. V.
    Feld, J.
    Galsky, M. D.
    Choueiri, T. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1204 - S1204
12345